Target- |
Mechanism- |
|
|
Active Indication- |
Inactive Indication- |
Drug Highest PhasePhase 1 |
First Approval Ctry. / Loc.- |
First Approval Date- |
/ Not yet recruitingPhase 1 A Phase 1 Randomized, Double-blind, Placebo-controlled, Single and Multiple Ascending Dose Study to Evaluate the Safety and Pharmacokinetics of TL-001 in Healthy Adult Participants
The goal of this study is to evaluate safety, tolerability, pharmacokinetics (PK)), pharmacodynamics (PD) and immunogenicity of single and multiple ascending dose of TL-001 in healthy adult participants.
100 Clinical Results associated with TrueLab Biopharmaceutical Co., Ltd
0 Patents (Medical) associated with TrueLab Biopharmaceutical Co., Ltd
100 Deals associated with TrueLab Biopharmaceutical Co., Ltd
100 Translational Medicine associated with TrueLab Biopharmaceutical Co., Ltd